| scholarly article | Q13442814 |
| P50 | author | Farhad Ravandi | Q40614280 |
| Jorge Eduardo Cortes | Q60320900 | ||
| Hagop Kantarjian | Q60394812 | ||
| Gautam Borthakur | Q66370731 | ||
| Tapan Kadia | Q66370733 | ||
| Alfonso Quintas-Cardama | Q66370882 | ||
| Guillermo Garcia-Manero | Q66385413 | ||
| Michael J. Keating | Q66429598 | ||
| Graciela M Nogueras-Gonzalez | Q87214855 | ||
| Naveen Pemmaraju | Q87733857 | ||
| Naval Daver | Q88327648 | ||
| Lynne V Abruzzo | Q96099267 | ||
| Aziz Nazha | Q114427910 | ||
| P2093 | author name string | Vijaya R Bhatt | |
| P2860 | cites work | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Q22299206 |
| Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients | Q31892904 | ||
| Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. | Q33397876 | ||
| The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients | Q34288377 | ||
| Cytogenetics in acute leukemia | Q34304230 | ||
| Cytarabine dose for acute myeloid leukemia | Q34627648 | ||
| Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype | Q36808186 | ||
| Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience | Q37006786 | ||
| Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia | Q37635209 | ||
| 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ | Q38503283 | ||
| The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia | Q40009452 | ||
| Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia | Q40543180 | ||
| Mutation of the p53 gene in human acute myelogenous leukemia | Q41688717 | ||
| Clofarabine combinations as acute myeloid leukemia salvage therapy | Q42048738 | ||
| Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. | Q43102402 | ||
| Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia | Q46169540 | ||
| The impact of abn(17p) and monosomy -5/del(5q) on the prognostic value of the monosomal karyotype in acute myeloid leukemia | Q46189022 | ||
| Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-. | Q46521483 | ||
| Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia. | Q46735727 | ||
| Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival. | Q47826998 | ||
| TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. | Q50629545 | ||
| Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. | Q55067694 | ||
| Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results | Q59413209 | ||
| Mutations of the P53 gene in acute myeloid leukaemia | Q68077839 | ||
| Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype | Q81402320 | ||
| Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype | Q81769874 | ||
| Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies | Q82568634 | ||
| Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity | Q82696653 | ||
| TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome | Q83080803 | ||
| Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype | Q83154836 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | karyotype | Q189967 |
| acute myeloid leukemia | Q264118 | ||
| P304 | page(s) | 163-171 | |
| P577 | publication date | 2014-01-22 | |
| P1433 | published in | Clinical Lymphoma, Myeloma & Leukemia | Q5133774 |
| P1476 | title | Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics | |
| P478 | volume | 14 |
| Q52953786 | Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG). |
| Q57058970 | Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care |
| Q36474066 | Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies |
| Q38760193 | Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials |
Search more.